Paracoccidioidomycosis

Current Fungal Infection Reports

Volumn 3, Issue 1, 2009, Pages 15-20

  Nucci, Marcio ^a   Colombo, Arnaldo L ^b   Queiroz Telles, Flavio ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PEPTIDE DERIVATIVE; PEPTIDE P10; POSACONAZOLE; SULFADIAZINE; TERBINAFINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGRICULTURE; ANTIGEN DETECTION; CLINICAL FEATURE; COFFEE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ENDEMIC DISEASE; FUNGUS CULTURE; GENE AMPLIFICATION; HUMAN; INCIDENCE; INHALATION; LUNG INFECTION; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RURAL POPULATION; SERODIAGNOSIS; SOUTH AMERICAN BLASTOMYCOSIS; SUGARCANE; SYMPTOM; TREATMENT RESPONSE;

EID: 77953417942     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-009-0003-0     Document Type: Review

References (50)

1. Ramos-E-Silva M, Saraiva LE: Paracoccidioidomycosis. Dermatol Clin 2008, 26:257-269.
2. Blotta MH, Mamoni RL, Oliveira SJ, et al.Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg 1999, 61:390-394.
3. Van Damme PA, Bierenbroodspot F, Telgtt DS, et al.A case of imported paracoccidioidomycosis: an awkward infection in The Netherlands. Med Mycol 2006, 44:13-18.
4. Mayayo E, Lopez-Aracil V, Fernandez-Torres B, et al.Report of an imported cutaneous disseminated case of paracoccidioidomycosis. Rev Iberoam Micol 2007, 24:44-46.
5. Bousquet A, Dussart C, Drouillard I, et al.Imported mycosis: a review of paracoccidioidomycosis [in French]. Med Mal Infect 2007, 37(Suppl 3):S210-S214.
6. Walker SL, Pembroke AC, Lucas SB, Vega-Lopez F: Paracoccidioidomycosis presenting in the UK. Br J Dermatol 2008, 158:624-626.
7. Fava S di, Netto CF: Epidemiologic surveys of histoplasmin and paracoccidioidin sensitivity in Brazil. Rev Inst Med Trop Sao Paulo 1998, 40:155-164.
8. Bittencourt JI, de Oliveira RM, Coutinho ZF: Paracoccidioidomycosis mortality in the State of Parana, Brazil, 1980/1998. Cad Saude Publica 2005, 21:1856-1864.
9. Coutinho ZF, Silva D, Lazera M, et al.Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica 2002, 18:1441-1454.
10. Travassos LR, Taborda CP, Colombo AL: Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther 2008, 6:251-262.
11. Colombo AL: Paracoccidioidomycosis: advances and unmet needs 100 years after its initial description by Lutz. J Venom Anim Toxins incl Trop Dis 2008, 14:387-392.
12. Bagagli E, Theodoro RC, Bosco SM, McEwen JG: Paracoccidioides brasiliensis: phylogenetic and ecological aspects. Mycopathologia 2008, 165:197-207. This article reviews the phylogeny of the fungus and its relationship with ecologic features.
13. Theodoro RC, Bagagli E, Oliveira C: Phylogenetic analysis of PRP8 intein in Paracoccidioides brasiliensis species complex. Fungal Genet Biol 2008, 45:1284-1291.
14. Corte AC, Svoboda WK, Navarro IT, et al.Paracoccidioidomycosis in wild monkeys from Parana State, Brazil. Mycopathologia 2007, 164:225-228.
15. Silveira LH, Paes RC, Medeiros EV, et al.Occurrence of Antibodies to Paracoccidioides brasiliensis in dairy cattle from Mato Grosso do Sul, Brazil. Mycopathologia 2008, 165:367-371.
16. Franco M, Bagagli E, Scapolio S, da Silva Lacaz C: A critical analysis of isolation of Paracoccidioides brasiliensis from soil. Med Mycol 2000, 38:185-191.
17. Calle D, Rosero DS, Orozco LC, et al.Paracoccidioidomycosis in Colombia: an ecological study. Epidemiol Infect 2001, 126:309-315.
18. Queiroz-Telles F: Influence of alternating coffee and sugar cane agriculture in the incidence of paracoccidioidomycosis in Brazil. Biomedica 2008, 28(Suppl 1):129
19. Restrepo A, Salazar ME, Cano LE, et al.Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun 1984, 46:346-353.
20. Wanke B, Londero AT: Epidemiology and paracoccidioidomycosis infection. In: Paracoccidioidomycosis. Edited by Franco M, Lacaz CS, Restrepo-Moreno A. Boca Raton, FL: CRC Press; 1994:109-117.
21. Paniago AM, de Freitas AC, Aguiar ES, et al.Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect 2005, 51:248-252.
22. Shikanai-Yasuda MA, Conceicao YM, Kono A, et al.Neoplasia and paracoccidioidomycosis. Mycopathologia 2008, 165:303-312.
23. Calich VL, Pina A, Felonato M, et al.Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol Med Microbiol 2008, 53:1-7.
24. Calich VL, da Costa TA, Felonato M, et al.Innate immunity to Paracoccidioides brasiliensis infection. Mycopathologia 2008, 165:223-236.
25. Benard G: An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia 2008, 165:209-221.
26. Colombo AL, Faical S, Kater CE: Systematic evaluation of the adrenocortical function in patients with paracoccidioidomycosis. Mycopathologia 1994, 127:89-93.
27. Benard G, Duarte AJ: Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis 2000, 31:1032-1039.
28. Brummer E, Castaneda E, Restrepo A: Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993, 6:89-117.
29. de Camargo ZP: Serology of paracoccidioidomycosis. Mycopathologia 2008, 165:289-302.
30. Queiroz-Telles F, Colombo AL, Nucci M: Comparative efficacy of cotrimoxazole and itraconazole in the treatment of paracoccidioidomycosis [abstract]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA; September 24-27, 1998.
31. Gomez BL, Figueroa JI, Hamilton AJ, et al.Antigenemia in patients with paracoccidioidomycosis: detection of the 87-kilodalton determinant during and after antifungal therapy. J Clin Microbiol 1998, 36:3309-3316.
32. Marques da Silva SH, Colombo AL, Blotta MH, et al.Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis. J Clin Microbiol 2003, 41:3675-3680.
33. Marques da Silva SH, Queiroz-Telles F, Colombo AL, et al.Monitoring gp43 antigenemia in Paracoccidioidomycosis patients during therapy. J Clin Microbiol 2004, 42:2419-2424.
34. Mendes-Giannini MJ, Bueno JP, Shikanai-Yasuda MA, et al.Detection of the 43,000-molecular-weight glycoprotein in sera of patients with paracoccidioidomycosis. J Clin Microbiol 1989, 27:2842-2845.
35. da Silva SH, Colombo AL, Blotta MH, et al.Diagnosis of neuroparacoccidioidomycosis by detection of circulating antigen and antibody in cerebrospinal fluid. J Clin Microbiol 2005, 43:4680-4683.
36. da Silva SH, Grosso Dde M, Lopes JD, et al.Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy. J Clin Microbiol 2004, 42:4480-4486.
37. Motoyama AB, Venancio EJ, Brandao GO, et al.Molecular identification of Paracoccidioides brasiliensis by PCR amplification of ribosomal DNA 9. J Clin Microbiol 2000, 38:3106-3109.
38. Gomes GM, Cisalpino PS, Taborda CP, de Camargo ZP: PCR for diagnosis of paracoccidioidomycosis. J Clin Microbiol 2000, 38:3478-3480.
39. San-Blas G, Nino-Vega G, Barreto L, et al.Primers for clinical detection of Paracoccidioides brasiliensis. J Clin Microbiol 2005, 43:4255-4257.
40. Stevens DA, Vo PT: Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis. Antimicrob Agents Chemother 1982, 21:852-854.
41. Menezes VM, Soares BG, Fontes CJ: Drugs for treating paracoccidioidomycosis. Cochrane Database Syst Rev 2006, CD004967.
42. Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, et al.Guidelines in paracoccidioidomycosis [in Portuguese]. Rev Soc Bras Med Trop 2006, 39:297-310.
43. Shikanai-Yasuda MA, Benard G, Higaki Y, et al.Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. Med Mycol 2002, 40:411-417.
44. Queiroz-Telles F, Goldani LZ, Schlamm HT, et al.An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis 2007, 45:1462-1469.
45. Naranjo MS, Trujillo M, Munera MI, et al.Treatment of paracoccidioidomycosis with itraconazole. J Med Vet Mycol 1990, 28:67-76.
46. de Campos EP, Sartori JC, Hetch ML, de Franco MF: Clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin B. Rev Inst Med Trop Sao Paulo 1984, 26:212-217.
47. Dillon NL, Sampaio SA, Habermann MC, et al.Delayed results of treatment of paracoccidioidomycosis with amphotericin B plus sulfamides versus amphotericin B alone. Rev Inst Med Trop Sao Paulo 1986, 28:263-266.
48. Dietze R, Fowler VG Jr, Steiner TS, et al.Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis. Am J Trop Med Hyg 1999, 60:837-839. (Pubitemid 29233090)
49. Tobon A, Agudelo CA, Restrepo A: Posaconazole for the treatment of paracoccidioidomycosis: first clinical results. Biomedica 2008, 28(Suppl 1):205.
50. Marques AF, da Silva MB, Juliano MA, et al.Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 2006, 50:2814-2819.